Estratégias terapêuticas no manejo do risco suicida

Gabriela Garcia de Carvalho Laguna; Ana Beatriz Ferreira Gusmão; Ana Luiza Ferreira Gusmão; David Santos Libarino; Katiene Rodrigues Menezes De Azevedo

doi:10.22481/rsc.v19i2.12256

Autores

Gabriela Garcia de Carvalho Laguna Instituto Multidisciplinar em Saúde da Universidade Federal da Bahia https://orcid.org/0000-0001-7396-647X
Ana Beatriz Ferreira Gusmão Instituto Multidisciplinar em Saúde da Universidade Federal da Bahia https://orcid.org/0000-0002-7218-5505
Ana Luiza Ferreira Gusmão Instituto Multidisciplinar em Saúde da Universidade Federal da Bahia https://orcid.org/0000-0001-7087-5935
David Santos Libarino Instituto Multidisciplinar em Saúde da Universidade Federal da Bahia https://orcid.org/0000-0002-7763-5026
Katiene Rodrigues Menezes De Azevedo Instituto Multidisciplinar em Saúde da Universidade Federal da Bahia https://orcid.org/0000-0002-2990-5351

DOI:

https://doi.org/10.22481/rsc.v19i2.12256

Resumo

Objetivo. Descrever as principais estratégias terapêuticas úteis visando o manejo do risco suicida. Método. Trata-se de uma revisão narrativa, que incluiu artigos publicados entre 2018 e 2023 nas bases de dados PubMed, BVS, SciELO, Periódicos CAPES e Google Scholar. Para as buscas, diversos descritores foram combinados com: “Suicide”, “Suicidal Ideation” e “Ideations, Suicidal”. Resultados. Quanto aos hábitos de vida, destacam-se: qualidade do sono, prática regular de exercícios físicos e senso de identificação e de pertencimento a uma comunidade. Dentre as terapias psicológicas, a Terapia Cognitivo Comportamental (TCC) e a Terapia Comportamental Dialética apresentam melhores evidências. Com relação às medidas farmacológicas e procedimentais, o acompanhamento da condição de base, quando existente, é determinante na escolha da opção terapêutica e destaca-se a importância de redobrar os cuidados com pessoas que já tentaram suicidio. Para transtornos de humor, o Lítio pode proporcionar boa resposta no manejo do risco suicida, além de antidepressivos e da associação deles com terapias psicológicas, sobretudo a TCC. A Cetamina e a eletroconvulsoterapia também são possibilidades promissoras, principalmente pela rápida melhora na crise. Conclusão. Apresentamos um panorama de ferramentas úteis para o cuidado em saúde mental que pode contribuir para otimizar a assistência diante do risco suicida.

Downloads

Não há dados estatísticos.

Referências

WORLD HEALTH ORGANIZATION (WHO). World mental health report: Transforming mental health for all. Geneva: World Health Organization, 2022.

NATIONAL INSTITUTE OF MENTAL HEALTH. Suicide. [S. l.]: NIMH, [20--]. Disponível em: https://www.nimh.nih.gov/health/statistics/suicide. Acesso em: 29 jan. 2023.

CHAN, M. K. Y. et al. Predicting suicide following self-harm: systematic review of risk factors and risk scales. British Journal of Psychiatry, [s. l.], v. 209, p. 277–283, 2016.

SPOTTSWOOD, M. et al. Improving Suicide Prevention in Primary Care for Differing Levels of Behavioral Health Integration: A Review. Frontiers in Medicine, [s. l.], v. 9, 892205, 2022.

GØTZSCHE, P. C.; GØTZSCHE, P. K. Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. Journal of the Royal Society of Medicine, [s. l.], v. 110, p. 404–410, 2017.

KREITMAN, N. (ed.). Parasuicide. London: John Wiley & Sons, 1977. Resenha em: Psychological Medicine, [s. l.], v. 8, p. 539–540, 1978.

NABI, Z. et al. Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiology and Psychiatric Sciences, [s. l.], v. 31, 2022. DOI: 10.1017/s204579602200049x.

D’ANCI, K. E.; UHL, S. Treatments for the Prevention and Management of Suicide. Annals of Internal Medicine, [s. l.], v. 172, p. 168, 2020.

ROTHER, E. T. Revisão sistemática X revisão narrativa. Acta Paulista de Enfermagem, São Paulo, v. 20, p. v–vi, 2007.

BAETHGE, C.; GOLDBACK-WOOD, S.; MERTENS, S. SANRA - a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review, [s. l.], 2019. DOI: 10.1186/s41073-019-0064-8.

MESH-NCBI. [S. l.: s. n.], [20--]. Disponível em: https://www.ncbi.nlm.nih.gov/mesh/. Acesso em: 16 jan. 2023.

PERLIS, M. L. et al. Suicide and sleep: Is it a bad thing to be awake when reason sleeps?. Sleep Medicine Reviews, [s. l.], v. 29, p. 101–107, 2016.

KIM, M. J.; SHIN, D.; AHN, Y. M. Association between the number of hours of sleep during weekdays and suicidality among Korean adolescents: Mediating role of depressive and anxiety symptoms. Journal of Affective Disorders, [s. l.], v. 320, p. 74–80, 2023.

HAMILTON, J. L. et al. Sleep influences daily suicidal ideation through affective reactivity to interpersonal events among high‐risk adolescents and young adults. Journal of Child Psychology and Psychiatry, [s. l.], v. 64, p. 27–38, 2023.

KALMBACH, D. A. et al. Cognitive-behavioral therapy for insomnia prevents and alleviates suicidal ideation: insomnia remission is a suicidolytic mechanism. Sleep, [s. l.], v. 45, 2022. DOI: 10.1093/sleep/zsac251.

KIM, H. J. et al. The Effects of Intense Physical Activity on Stress in Adolescents: Findings from Korea Youth Risk Behavior Web-Based Survey (2015-2017). International Journal of Environmental Research and Public Health, [s. l.], v. 16, 2019. DOI: 10.3390/ijerph16101870.

VANCAMPFORT, D. et al. Physical activity and suicidal ideation: A systematic review and meta-analysis. Journal of Affective Disorders, [s. l.], v. 225, p. 438–448, 2018.

SCARTH, B. et al. Strategies to Stay Alive: Adaptive Toolboxes for Living Well with Suicidal Behavior. International Journal of Environmental Research and Public Health, [s. l.], v. 18, 2021. DOI: 10.3390/ijerph18158013.

PLÖDERL, M.; KUNRATH, S.; FARTACEK, C. God Bless You? The Association of Religion and Spirituality with Reduction of Suicide Ideation and Length of Hospital Stay among Psychiatric Patients at Risk for Suicide. Suicide and Life-Threatening Behavior, [s. l.], v. 50, p. 95–110, 2020.

LUSK, J. et al. Spirituality, Religion, and Suicidality Among Veterans: A Qualitative Study. Archives of Suicide Research, [s. l.], v. 22, p. 311–326, 2018.

VITALE, A. et al. Effectiveness of Complementary and Integrative Approaches in Promoting Engagement and Overall Wellness Toward Suicide Prevention in Veterans. Journal of Alternative and Complementary Medicine, [s. l.], v. 27, p. S14–S27, 2021.

MEORE, A. et al. Pilot evaluation of horticultural therapy in improving overall wellness in veterans with history of suicidality. Complementary Therapies in Medicine, [s. l.], v. 59, 102728, 2021.

GUTIERREZ, P. M. et al. Pilot study of the Collaborative Assessment and Management of Suicidality-Group. Suicide and Life-Threatening Behavior, [s. l.], v. 52, p. 244–255, 2022.

AMADÉO, S. et al. Supportive effect of body contact care with ylang ylang aromatherapy and mobile intervention team for suicide prevention: A pilot study. Journal of International Medical Research, [s. l.], v. 48, 2020.

ROBERGE, E. M. et al. Variables associated with reductions in insomnia severity among acutely suicidal patients receiving brief cognitive behavioral therapy for suicide prevention. Journal of Affective Disorders, [s. l.], v. 252, p. 230–236, 2019.

PIGEON, W. R. et al. Brief CBT for insomnia delivered in primary care to patients endorsing suicidal ideation: a proof-of-concept randomized clinical trial. Translational Behavioral Medicine, [s. l.], v. 9, p. 1169–1177, 2019.

RAJ, S. et al. Effectiveness of mindfulness based cognitive behavior therapy on life satisfaction, and life orientation of adolescents with depression and suicidal ideation. Asian Journal of Psychiatry, [s. l.], v. 39, p. 58–62, 2019.

SCHMELEFSKE, E. et al. The Effects of Mindfulness-Based Interventions on Suicide Outcomes: A Meta-Analysis. Archives of Suicide Research, [s. l.], v. 26, p. 447–464, 2022.

ESPOSITO-SMYTHERS, C. et al. Family-focused cognitive behavioral treatment for depressed adolescents in suicidal crisis with co-occurring risk factors: a randomized trial. Journal of Child Psychology and Psychiatry, [s. l.], v. 60, p. 1133–1141, 2019.

MEHLUM, L. et al. Long-term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior. Journal of Child Psychology and Psychiatry, [s. l.], v. 60, p. 1112–1122, 2019.

D’ANCI, K. E. et al. Treatments for the Prevention and Management of Suicide: A Systematic Review. Annals of Internal Medicine, [s. l.], v. 171, p. 334–342, 2019.

PEÑAS-LLEDÓ, E. M. et al. A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts. Translational Psychiatry, [s. l.], v. 12, 2022. DOI: 10.1038/s41398-022-02140-4.

KRINGEN, M. K. et al. The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort. Journal of Clinical Psychopharmacology, [s. l.], v. 40, 2020. DOI: 10.1097/JCP.0000000000001174.

PARIS, J. Suicidality in Borderline Personality Disorder. Medicina, [s. l.], v. 55, 2019. DOI: 10.3390/medicina55060223.

SAIGLE, V.; RACINE, E. Ethical challenges faced by healthcare professionals who care for suicidal patients: a scoping review. Monash Bioethics Review, [s. l.], v. 35, p. 50–79, 2018.

ZHOU, X. et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. The Lancet Psychiatry, [s. l.], v. 7, 2020. DOI: 10.1016/S2215-0366(20)30137-1.

CHIN, T. et al. Traitement antidépresseur personnalisé pour les patients souffrant d’un trouble dépressif caractérisé: Outil novateur d'aide à la décision fondé sur des données probantes. Canadian Family Physician, [s. l.], v. 68, p. e301–e309, 2022.

STAHL, S. M. Fundamentos de psicofarmacologia de Stahl: guia de prescrição. 6. ed. Porto Alegre: Artmed, 2018. 313 p.

QRIOUET, Z. et al. Analytical Methods Used for the Detection and Quantification of Benzodiazepines. Journal of Analytical Methods in Chemistry, [s. l.], 2019. DOI: 10.1155/2019/2035492.

DOLD, M. et al. Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study. European Neuropsychopharmacology, [s. l.], v. 41, p. 70–80, 2020.

SUNG, H. G. et al. Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case-control and case-crossover study. Social Psychiatry and Psychiatric Epidemiology, [s. l.], v. 54, 2019. DOI: 10.1007/s00127-019-01713-x.

MCINTYRE, R. S. et al. Bipolar disorders. The Lancet, [s. l.], v. 396, 2020. DOI: 10.1016/S0140-6736(20)31544-0.

WORTZEL, H. S. et al. Lithium Use for Suicide Prevention, Revisited. Journal of Psychiatric Practice, [s. l.], v. 29, p. 51–57, 2023.

WARRIACH, Z. I.; SANCHEZ-GONZALEZ, M. A.; FERRER, G. F. Suicidal Behavior and Medication Adherence in Schizophrenic Patients. Cureus, [s. l.], v. 13, 2021. DOI: 10.7759/cureus.12473.

KHOKHAR, J. Y. et al. Unique Effects of Clozapine: A Pharmacological Perspective. Advances in Pharmacology, [s. l.], v. 82, p. 137, 2018.

GALES, A.; MAXWELL, S. Cetamina: Evidências Recentes e Usos Atuais. [S. l.]: Anesthesia Tutorial of the Week, 2018. Disponível em: https://www.sbahq.org/wp-content/uploads/2018/07/381_portugues.pdf. Acesso em: 8 fev. 2023.

CORRIGER, A.; PICKERING, G. Ketamine and depression: a narrative review. Drug Design, Development and Therapy, [s. l.], v. 13, p. 3051, 2019.

LAGUNA, G. G. C.; DE CARVALHO, L. S.; DE AZEVEDO, K. R. M. Eletroconvulsoterapia no manejo do risco suicida. Revista Neurociências, [s. l.], v. 30, p. 1–19, 2022. DOI: 10.34024/rnc.2022.v30.14294.

RÖNNQVIST, I.; NILSSON, F. K.; NORDENSKJÖLD, A. Electroconvulsive Therapy and the Risk of Suicide in Hospitalized Patients With Major Depressive Disorder. JAMA Network Open, [s. l.], v. 4, 2021. DOI: 10.1001/jamanetworkopen.2021.16589.

KASTER, T. S. et al. Risk of serious medical events in patients with depression treated with electroconvulsive therapy: a propensity score-matched, retrospective cohort study. The Lancet Psychiatry, [s. l.], v. 8, 2021. DOI: 10.1016/S2215-0366(21)00168-1.